Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Archer

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Nuclear Medicine and Biology|May 1, 1996
Chimeric anti-tenascin antibody 81C6: increased tumor localization compared with its murine parentM R Zalutsky, G E Archer, P K Garg, et al.
Cancer Research|April 15, 1997
Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylateC J Reist, G E Archer, C J Wikstrand, et al.
Biotechniques|February 24, 2001
Maximization of signal derived from cDNA microarraysS E Wildsmith, G E Archer, A J Winkley, et al.
Journal of Neurovirology|May 19, 1998
The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic targetC J Wikstrand, C J Reist, G E Archer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1994
PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragmentR L Page, P K Garg, S Garg, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 1999
Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysisR E McLendon, G E Archer, R H Larsen, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1996
Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermiaM R Zalutsky, J M Schuster, P K Garg, et al.
Cancer Research|September 1, 1994
Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugateM R Zalutsky, R E McLendon, P K Garg, et al.
Journal of Neuroimmunology|October 23, 1997
A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivoD M Ashley, J H Sampson, G E Archer, et al.
Environmental and Molecular Mutagenesis|October 26, 1999
Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in MutaMouseC C Smith, G E Archer, E J Forster, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Nuclear Medicine and Biology|May 1, 1996
Chimeric anti-tenascin antibody 81C6: increased tumor localization compared with its murine parentM R Zalutsky, G E Archer, P K Garg, et al.
Cancer Research|April 15, 1997
Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylateC J Reist, G E Archer, C J Wikstrand, et al.
Biotechniques|February 24, 2001
Maximization of signal derived from cDNA microarraysS E Wildsmith, G E Archer, A J Winkley, et al.
Journal of Neurovirology|May 19, 1998
The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic targetC J Wikstrand, C J Reist, G E Archer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1994
PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragmentR L Page, P K Garg, S Garg, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 1999
Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysisR E McLendon, G E Archer, R H Larsen, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1996
Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermiaM R Zalutsky, J M Schuster, P K Garg, et al.
Cancer Research|September 1, 1994
Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugateM R Zalutsky, R E McLendon, P K Garg, et al.
Journal of Neuroimmunology|October 23, 1997
A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivoD M Ashley, J H Sampson, G E Archer, et al.
Environmental and Molecular Mutagenesis|October 26, 1999
Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in MutaMouseC C Smith, G E Archer, E J Forster, et al.
Pageof 5